Clinical Trial

Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes

Study acronym: ERFA
Completed
View on ClinicalTrials.gov →
Summary
This single-center, prospective study evaluates the therapeutic outcomes of saline-augmented bipolar radiofrequency ablation (RFA) with twin internally cooled-perfusion (TICP) electrodes for treating recurrent hepatocellular carcinoma (HCC) following trans-arterial chemoembolization (TACE).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-17.
Trial Details
NCT Number NCT07192172
Lead Sponsor Seoul National University Hospital
Conditions Hepatocellular Carcinoma, Liver Neoplasms
Enrollment 100 participants
Start Date 2017-09-01
Primary Completion 2019-01-31 (estimated)
Study Completion 2020-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13